FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on: November 07,2024

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on:November 07,2024

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t

Updated on: January 22,2024

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t

Updated on:January 22,2024

Study reveals significant global disparities in cancer care across different countries

byWileyCredit: Pixabay/CC0 Public DomainA recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps b

Updated on: November 30,2024

Study reveals significant global disparities in cancer care across different countries

byWileyCredit: Pixabay/CC0 Public DomainA recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps b

Updated on:November 30,2024

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Updated on: November 10,2024

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Updated on:November 10,2024

New genetic test for pancreatic cancer outperforms current guidelines

by University of PittsburghCredit: Pixabay/CC0 Public DomainA molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, mul

Updated on: January 30,2024

New genetic test for pancreatic cancer outperforms current guidelines

by University of PittsburghCredit: Pixabay/CC0 Public DomainA molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, mul

Updated on:January 30,2024

Researchers: Favorable survival, fewer side effects after reduced therapy for HPV-linked head and neck cancer

by University of North Carolina at Chapel Hill School of MedicineBhisham Chera, MD. Credit: University of North Carolina at Chapel Hill School of MedicineUniversity of North Carolina Lineberger C

Updated on: March 01,2024

Researchers: Favorable survival, fewer side effects after reduced therapy for HPV-linked head and neck cancer

by University of North Carolina at Chapel Hill School of MedicineBhisham Chera, MD. Credit: University of North Carolina at Chapel Hill School of MedicineUniversity of North Carolina Lineberger C

Updated on:March 01,2024

Super-soldier T-cells fight cancer better after a transformational DNA delivery

by Andy Tay,The ConversationCredit: Ketut Subiyanto from PexelsI enjoy online shopping. However, I often find myself fussing about the delivery options during checkout. This is because not all d

Updated on: April 01,2024

Super-soldier T-cells fight cancer better after a transformational DNA delivery

by Andy Tay,The ConversationCredit: Ketut Subiyanto from PexelsI enjoy online shopping. However, I often find myself fussing about the delivery options during checkout. This is because not all d

Updated on:April 01,2024

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on: May 26,2024

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on:May 26,2024

Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

by National Research University Higher School of EconomicsCredit: CC0 Public DomainScientists at the Higher School of Economics, the Institute of Bioorganic Chemistry of the Russian Academy of Science

Updated on: June 24,2024

Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

by National Research University Higher School of EconomicsCredit: CC0 Public DomainScientists at the Higher School of Economics, the Institute of Bioorganic Chemistry of the Russian Academy of Science

Updated on:June 24,2024

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint

Updated on: March 25,2024

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint

Updated on:March 25,2024

Genetic discovery could improve treatment of colorectal cancer

by Rémi Carlier,Ecole Polytechnique Federale de LausannePOU5F1B differs from OCT4. a Representative immunofluorescence–confocal microscopy of POU5F1B-HA overexpressing SW480 cells, with DAPI in

Updated on: December 25,2023

Genetic discovery could improve treatment of colorectal cancer

by Rémi Carlier,Ecole Polytechnique Federale de LausannePOU5F1B differs from OCT4. a Representative immunofluorescence–confocal microscopy of POU5F1B-HA overexpressing SW480 cells, with DAPI in

Updated on:December 25,2023

The role of p53 as a target for novel cancer therapies

by Erika Rindsjö,Karolinska InstitutetComplex interplay between TP53-mutant cancer cells and their microenvironment. Credit:Nature Reviews Clinical Oncology(2023). DOI: 10.1038/s4157

Updated on: December 30,2023

The role of p53 as a target for novel cancer therapies

by Erika Rindsjö,Karolinska InstitutetComplex interplay between TP53-mutant cancer cells and their microenvironment. Credit:Nature Reviews Clinical Oncology(2023). DOI: 10.1038/s4157

Updated on:December 30,2023